Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Typesort ascending Project # RFA # PI/Project Leader Institution Title Status
2021 R21 CA20-017 SCHULMAN, REBECCA JOHNS HOPKINS UNIVERSITY Secretion responsive Hydrogels for Identification of Functional single T cells (SHIFT) Active
1999 R21 PAR-98-067 BRADLEY, ALLAN BAYLOR COLLEGE OF MEDICINE DEVELOPMENT OF BAC ARRAY COMPARITIVE GENOMIC HYBRIDIZATI Complete
2007 R21 RFA-CA-07-003 BEEBE, DAVID J UNIVERSITY OF WISCONSIN-MADISON MICROFLUIDIC CHANNELS FOR HIGH DENSITY, HIGH PERFORMANCE CULTURE ASSAYS Complete
2010 R21 RFA-CA-09-004 HANSEN, KIRK C UNIVERSITY OF COLORADO DENVER METHODS FOR THE ANALYSIS OF TUMOR EXTRACELLULAR MATRIX Complete
2014 R21 RFA-CA-13-001 TEMPST, PAUL SLOAN-KETTERING INST CAN RESEARCH IMMOBILIZED PROTEASE ACTIVITY TESTS FOR DEVELOPING FUNCTIONAL CANCER BIOMARKERS. Complete
2017 R21 RFA-CA-16-001 DAVIS, RONALD WAYNE STANFORD UNIVERSITY Nanoneedle microrobots for single cancer cell manipulation and genome editing Complete
2009 R21 RFA-CA-08-006 RIEHN, ROBERT NORTH CAROLINA STATE UNIVERSITY RALEIGH EPIGENETIC PROFILING BY NEAR-FIELD UV-RAMAN SCATTERING IN NANOCHANNELS Complete
2013 R21 RFA-CA-12-002 FAN, RONG YALE UNIVERSITY HIGH-THROUGHPUT, MULTIPLEXED DETECTION OF MIRNA BIOMARKERS IN SINGLE CANCER CELLS Complete
2020 R21 RFA-CA-19-019 HUR, SOOJUNG CLAIRE JOHNS HOPKINS UNIVERSITY Development of a microfluidic primary cell editing platform (pCEP) for personal gene therapy Complete
2000 R21 PAR-99-102 WEIER, HEINZ-ULRICH G UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB SPECTRAL IMAGING FOR PHENOTYPE ANALYSIS OF CANCER CELLS Complete
2022 R21 RFA-CA-21-003 KNOWLES, DAVID ARTHUR NEW YORK GENOME CENTER A CRISPR/Cas13 approach for identifying individual transcript isoform function in cancer Active
2002 R21 PAR-01-106 BEITZ, ALVIN JAMES UNIVERSITY OF MINNESOTA TWIN CITIES IN VIVO ANALYSIS OF TUMOR PEPTIDE SECRETION Complete
2005 R21 RFA-CA-05-002 FRANK-KAMENETSKII, MAXIM D BOSTON UNIVERSITY FLUORESCENCE IN SITU DETECTION OF SHORT DNA SEQUENCES Complete
2008 R21 RFA-CA-07-033 KOIDE, SHOHEI UNIVERSITY OF CHICAGO HIGH-PERFORMANCE AFFINITY REAGENTS FOR PEPTIDE EPITOPES Complete
2011 R21 RFA-CA-10-001 HRUDKA, BRIAN BIOSPECIMEN PROCUREMENT SOLUTIONS, INC. DEVELOPMENT OF A SYSTEM (DEVICES AND PROTOCOLS) TO IMPROVE BIOSPECIMEN PRESERVATI Complete
2015 R21 RFA-CA-14-003 DRAKE, RICHARD R. MEDICAL UNIVERSITY OF SOUTH CAROLINA DIRECT TUMOR GLYCAN PROFILING ON TISSUE MICROARRAYS Complete
2018 R21 RFA-CA-17-010 ENGLER, ADAM JEFFREY UNIVERSITY OF CALIFORNIA, SAN DIEGO Developing Adhesome Technology as a Physical Marker of Highly Metastatic Cells Complete
2022 R21 CA21-003 SNYDER, JOSHUA CLAIR DUKE UNIVERSITY Mouse Paint: A massively combinatorial approach for illuminating tumor heterogeneity in True Color Active
1999 R21 PAR-98-067 SINGER, ROBERT H YESHIVA UNIVERSITY FISH AND CHIPS--SINGLE CELL EXPRESSION OF CANCER GENES Complete
2004 R21 PAR-01-104 MAYER, BRUCE J UNIVERSITY OF CONNECTICUT SCH OF MED/DNT A HIGH- MULTIPLEXED PHOSPHOTYROSINE PROFILING ASSAY Complete
2007 R21 RFA-CA-07-003 MUNN, LANCE L MASSACHUSETTS GENERAL HOSP MICROFLUIDIC DEVICE FOR ISOLATING RARE BLOOD CELLS Complete
2010 R21 RFA-CA-09-004 TSENG, HSIAN-RONG UNIVERSITY OF CALIFORNIA LOS ANGELES 3D-NANOSTRCUTURED SUBSTRATES FOR DETECTION OF CIRCULATING TUMOR CELLS Complete
2014 R21 RFA-CA-13-001 RIETHMAN, HAROLD WISTAR INSTITUTE A NOVEL SINGLE-MOLECULE TELOMERE CHARACTERIZATION TECHNOLOGY FOR ANALYZING CANCER Complete
2017 R21 RFA-CA-16-001 WONG, WESLEY PHILIP BOSTON CHILDREN'S HOSPITAL Single-molecule mechanical detection of protein and microRNA cancer biomarkers Complete
2003 R21 PAR-01-104 FERRARI, MAURO OHIO STATE UNIVERSITY NANOMECHANICAL METHOD FOR MOLECULAR ANALYSIS OF CANCER Complete
2009 R21 RFA-CA-08-007 YEN, YUN CITY OF HOPE/BECKMAN RESEARCH INSTITUTE ULTRAHIGH SENSITIVE, PERSONALIZED MONITORING OF LYMPHOMA RELAPSE USING BLOOD SPEC Complete
2013 R21 RFA-CA-12-002 LIOTTA, LANCE ALLEN GEORGE MASON UNIVERSITY PROTEIN PAINTING REVEALS HIDDEN PROTEIN-PROTEIN INTERACTION DOMAINS Complete
2020 R21 RFA-CA-19-019 REVZIN, ALEXANDER MAYO CLINIC ROCHESTER A microfluidic cell culture platform for personalizing pancreatic cancer therapies NCE
2000 R21 PAR-99-102 GALE, JAMES M UNIVERSITY OF NEW MEXICO MOLECULAR STAGING OF HUMAN SQUAMOUS CELL SKIN CANCER Complete
2002 R21 PAR-01-106 DYNAN, WILLIAM S MEDICAL COLLEGE OF GEORGIA (MCG) LASER CAPTURE MICROSCOPY AND 2D-DIGE: CANCER PROTEOMICS Complete
2005 R21 RFA-CA-05-002 BROWN, KATHLYNN C UNIVERSITY OF TEXAS SW MED CTR/DALLAS A HIGH THROUGHPUT DIAGNOSTIC ASSAY FOR LUNG CANCER Complete
2008 R21 RFA-CA-07-033 MORRISON, TOM B BIOTROVE, INC. STANDARDIZED NANOARRAY PCR FOR GENE EXPRESSION PROFILING OF LUNG CANCER Complete
2011 R21 RFA-CA-10-003 FISCHBACH, CLAUDIA CORNELL UNIVERSITY MINERALIZED 3-D TUMOR MODELS TO STUDY BREAST CANCER BONE METASTASIS Complete
2015 R21 RFA-CA-14-003 PRATX, GUILLEM STANFORD UNIVERSITY HIGH-THROUGHPUT RADIONUCLIDE COUNTING AND SORTING OF SINGLE CELLS Complete
2018 R21 RFA-CA-17-010 FIELDS, RYAN C WASHINGTON UNIVERSITY Advancing Cancer Biology, Diagnostics and Therapeutics Outside of the Patient: Creation of a Novel, Autologous, Ex Vivo, Vascularized Model of the Tumor Microenvironment Complete
2022 R21 CA21-003 GIBBS, SUMMER LYNNE OREGON HEALTH & SCIENCE UNIVERSITY A Novel Fluorescence Imaging Platform to Predict Response to Combinatorial Tyrosine Kinase Inhibitors Active
1999 R21 PAR-98-067 SHACKNEY, STANLEY E ALLEGHENY-SINGER RESEARCH INSTITUTE MOLECULAR PROFILING OF CELLS BY LASER SCANNING CYTOMETRY Complete
2004 R21 PAR-01-104 ZHAO, YINGMING UNIVERSITY OF TEXAS SW MED CTR/DALLAS A NOVEL PROTEOMICS TECHNOLOGY FOR PROTEIN FARNESYLATION Complete
2007 R21 RFA-CA-07-015 SAVRAN, CAGRI PURDUE UNIVERSITY WEST LAFAYETTE LABEL-FREE DETECTION OF CANCER MARKERS USING APTAZYME-BASED AMPLIFICATION Complete
2010 R21 RFA-CA-09-006 WALDMAN, TODD A GEORGETOWN UNIVERSITY DEVELOPMENT AND APPLICATION OF ENDOGENOUS EPITOPE TAGGING TECHNOLOGY IN HUMAN CEL Complete
2014 R21 RFA-CA-13-001 KUMAR, SANJAY UNIVERSITY OF CALIFORNIA BERKELEY MOLECULAR ANALYSIS OF PHYSICAL MICROENVIRONMENTAL CONTROL OF TUMOR CELL INVASION Complete
2017 R21 RFA-CA-16-001 KARGINOV, ANDREI V UNIVERSITY OF ILLINOIS AT CHICAGO Engineered regulation of tyrosine phosphatase activity in living cells Complete
2017 R21 RFA-CA-16-001 BROCK, AMY UNIVERSITY OF TEXAS, AUSTIN High resolution cell lineage tracking and isolation Complete
2021 R21 RFA-CA-20-019 SANTORE, MARIA M UNIVERSITY OF MASSACHUSETTS AMHERST Paper-based Breastmilk Collection System for Facile, In-Home Use Active
2001 R21 PAR-99-100 CONDEELIS, JOHN S YESHIVA UNIVERSITY NOVEL IMAGING METHODS FOR GENE DISCOVERY IN CANCER Complete
2003 R21 PAR-01-104 MAJUMDAR, ARUNAVA UNIVERSITY OF CALIFORNIA BERKELEY NANOCAPILLARY ELECTROPHORESIS FOR PROFILING CANCER Complete
2009 R21 RFA-CA-08-007 GODLEY, LUCY ANN UNIVERSITY OF CHICAGO A CHEMICAL CROSSLINKING STRATEGY TO DETERMINE DNA METHYLATING PROTEIN COMPLEXES Complete
2013 R21 RFA-CA-12-002 HARISMENDY, OLIVIER UNIVERSITY OF CALIFORNIA SAN DIEGO IN VIVO DETECTION AND GENOME-WIDE LOCATION ANALYSIS OF DNA-ADDUCTS Complete
2020 R21 RFA-CA-19-019 ISSADORE, DAVID AARON UNIVERSITY OF PENNSYLVANIA High Throughput Digital Droplet ELISA for Ultrasensitive Multiplexed Diagnostics NCE
2000 R21 PAR-98-066 HAMPDEN-SMITH, MARK J SUPERIOR MICROPOWDERS, LLC UNIQUE, SMALL PARTICLE PHOSPHOR POWDERS FOR IMUNOASSAYS Complete

Pages